NHS: Drugs

Department of Health and Social Care written question – answered at on 14 January 2019.

Alert me about debates like this

Photo of Justin Madders Justin Madders Shadow Minister (Business, Energy and Industrial Strategy) (Labour), Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, how patient organisations will be involved in the scoping for a review of NICE technology appraisal methods included in the 2019 voluntary scheme for branded medicines pricing and access.

Photo of Justin Madders Justin Madders Shadow Minister (Business, Energy and Industrial Strategy) (Labour), Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, when scoping will start for the review of NICE technology appraisal methods set out in the 2019 voluntary scheme for branded medicines pricing and access.

Photo of Justin Madders Justin Madders Shadow Minister (Business, Energy and Industrial Strategy) (Labour), Shadow Minister (Health and Social Care)

To ask the Secretary of State for Health and Social Care, whether the issue of combination treatments will be covered by the review of NICE technology appraisal methods set out in the 2019 voluntary scheme for branded medicines pricing and access.

Photo of Steve Brine Steve Brine The Parliamentary Under-Secretary for Health and Social Care

The National Institute for Health and Care Excellence has confirmed that scoping what will be considered within the technology appraisal methods review will start in 2019/20 and will involve industry and other relevant stakeholders, including patient organisations.

Does this answer the above question?

Yes1 person thinks so

No0 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.